lobbying_activities: 2104892

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2104892	2c54eed7-2c49-44e2-9f4a-2885b9f1d21d	Q1	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2018	first_quarter	PHA	Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Communication with Congress on compounding. Letter to Senate leadership regarding H.R. 1628, American Health Care Act of 2017. Testified to Senate on 340B Drug Discount Program. Communicated with House and Senate offices on drug shortages.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		200000	0	0	2018-04-12T12:54:34.977000-04:00